PME Symposia
PME Light Bites Symposium (Non-CME)
Friday, April 19 | 4:00 PM – 5:00 PM
A Treatment Option for Patients with Heart Failure
Sponsored by AstraZeneca Pharmaceuticals, LP.
Learning Objectives:
- Understand the prevalence and burden of HF in the US.
- Describe the use of Dapagliflozin (Farxiga) in patients with HF, the results of the Landmark DAPA-HF and DELIVER Trials.
- Describe Strategies for implementation of Dapagliflozin in clinical practice for the treatment of HF.
PME Breakfast Symposium (Non-CME)
Saturday, April 20 | 8:00 AM – 9:00 AM
More Than Just Weight Loss: Discover the Power of a GLP-1 RA
Sponsored by Novo Nordisk
Learning Objectives:
- Address obesity as a rising health problem in the US that is associated with other weight-related comorbidities and emphasize the pressing need to prioritize weight management.
- Evaluate the efficacy and safety data of an injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) for chronic weight management.
- Discuss data from selected trials that evaluated a GLP-1 RA as a chronic weight management therapy in adult patients with obesity or overweight and with a weight related comorbidity, in addition to lifestyle intervention.

